Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
| NCT ID | NCT04595565 |
| Title | Sacituzumab Govitecan in Primary HER2-negative Breast Cancer (SASCIA) |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase III |
| Variant Requirements | No |
| Sponsors | German Breast Group |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | ITA | FRA | ESP | DEU | BEL | AUT |